Hematology and Oncology Associates, Inc.

Canton, Ohio 44708

0 studies enrolling now · 5 studies all time

What they study most

Breast Carcinoma, Chemotherapy-Induced Nausea and Vomiting, Node Positive HER2 Negative Breast Cancer, Squamous Cell Carcinoma, Non-Small-Cell Lung, Stage III Distal Bile Duct Cancer AJCC v8, Stage III Gallbladder Cancer AJCC v8, Stage III Intrahepatic Cholangiocarcinoma AJCC v8, Stage IIIA Distal Bile Duct Cancer AJCC v8, Stage IIIA Gallbladder Cancer AJCC v8, Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8, Stage IIIB Distal Bile Duct Cancer AJCC v8, Stage IIIB Gallbladder Cancer AJCC v8

Studies at this site

• Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers — Completed
• Breast Cancer WEight Loss Study (BWEL Study) — Running, not enrolling
• Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy — Stopped early
• Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer — Completed
• A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting — Completed